Differential Modulation by Cations of Sigma and Phencyclidine Binding Sites in Rat Brain

References

• Martin W. R., Eades C. G., Thompson R. E., Huppler R. E., Gilbert P. E. The effects of morphine-and nalorphine-like drugs in the non-dependent and morphine dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976; 197: 517–532
   PubMed Web of Science ®Google Scholar
• Keats A. S., Telford J. Narcotic antagonists as analgesics: Clinical aspects. Molecular Modifications in Drug Design, R. F. Gould. Adv. Chem. Ser. 45, Am. Chem. Soc., Washington, DC 1964; 170–174
   Google Scholar
• Domino E. F. Neurobiology of phencyclidine (Serenyl), a drug with an unusual spectrum of pharmacological activity. Int. Rev. Neurobiol. 1964; 6: 303
   PubMed Web of Science ®Google Scholar
• Vincent J. P., Kartalovski B., Geneste P., Kamenka J. M., Lazdunski M. Interaction of phencyclidine (“angeldust”) with a specific receptor in rat brain. Proc. Natl. Acad. Sci. USA 1979; 76: 4678–4682
   PubMed Web of Science ®Google Scholar
• Zukin S. R., Zukin R. S. Specific [3H]phencyclidine binding in rat central nervous system. Proc. Natl. Acad. Sci. USA 1979; 76: 5372–5376
   PubMed Web of Science ®Google Scholar
• Su T. P. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea pig brain. J. Pharmacol. Exp. Ther. 1982; 223: 284–290
   PubMed Web of Science ®Google Scholar
• Tam S. W. Naloxone-inaccessible sigma receptor in rat central nervous system. Proc. Natl. Acad. Sci. USA 1983; 80: 6703–6707
   PubMed Web of Science ®Google Scholar
• Murray T. F., Leid M. E. Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes. Life Sci. 1984; 34: 1899–1911
   PubMedGoogle Scholar
• Brady K. T., Balster R. L., May E. L. Stereoisomers of N-Allylnormetazocine: Phencyclidine-like behavioral effects in squirrel monkeys and rats. Science 1982; 215: 178–180
   Google Scholar
• Holtzmann S. G. Phencyclidine-like discrimination effects of opioids in the rat. J. Pharmacol Exp. Ther. 1980; 214: 614–619
   Google Scholar
• Shannon H. E. Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat. J. Pharmacol. Exp. Ther. 1981; 216: 543–551
   PubMed Web of Science ®Google Scholar
• Shearman G. T., Herz A. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat. Eur. J. Pharmacol. 1982; 82: 167–172
   Google Scholar
• Zukin R. S., Zukin S. R. Multiple opiate receptors: Emerging concepts. Life Sci. 1981; 29: 2681–2690
   PubMedGoogle Scholar
• Tam S. W., Cook L. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H]SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. USA 1984; 81: 5618–5621
   PubMed Web of Science ®Google Scholar
• Largent B. L., Gundlach A. L., Snyder S. H. Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. Proc. Natl. Acad. Sci. USA 1984; 81: 4983–4987
   PubMed Web of Science ®Google Scholar
• Weber E., Sonders M., Quarum M., McLean S., Pou S., Keana J. F.W. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic and antipsychotic drugs. Proc. Natl. Acad. Sci. USA 1986; 83: 8784–8788
   PubMed Web of Science ®Google Scholar
• Ferris R. M., Tanf F. L. M., Chang K. J., Russel A. Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain. Life Sci. 1986; 38: 2329–2337
   Google Scholar
• Vignon J., Chicheportiche R., Chicheportiche M., Kamenka J. M., Geneste P., Lazdunski M. [3H]TCP: a new tool with high affinity for the PCP receptor in rat brain. Brain Research 1983; 280: 194–197
   PubMed Web of Science ®Google Scholar
• Costa T., Russel L., Pert C. B., Rodbard D. Halide- and gamma-aminobutyric acid-induced enhancement of diazepam receptors in rat brain. Mol. Pharmacol. 1981; 20: 470–476
   Google Scholar
• Schwarz S., Katki A. G., Zhou G. Z., Rovati E., Munson P. J., Rodbard D. μ1, and δ opioid receptors are differentially modulated by cations and GTP analogs. Modelling with quantitative LIGAND analysis. Progress in Opioid Research, Advances in the Biosciences. Pergamon Press Ltd., London 1989; vol. 75: 141–144
   Google Scholar
• Schwarz S., Pohl P., Zhou G. Z. Steroid binding at receptors. Science (Washington, D.C.) 1989; 246: 11635–1637
   Google Scholar
• Schwarz S., Katki A. G. Effects of calcium-channel blockers (CCB) on μml and δ opioid receptors in rat brain membranes, Progress in Clinical and Biological Research. Alan R. Liss, Inc., New York 1990; vol. 328: 109–112
   Google Scholar
• Itzhak Y., Hiller J. M., Simon E. J. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes. Mol. Pharmacol. 1985; 27: 46–52
   Google Scholar
• Vignon J., Vincent J. P., Bidard J. N., Kamenka J. M., Geneste P., Monier S., Lazdunski M. Biochemical properties of the phencyclidine receptor. Eur. J. Pharmacol. 1982; 81: 531–542
   Google Scholar
• Zhou G. Z., Katki A. G., Schwarz S., Munson P. J., Rodbard D. Demonstration of subtypes of “sigma” and phencyclidine receptors in rat brain membranes using quantitative LIGAND analysis. International Narcotics Research Conference, AlbiFrance, July, 3–81988, Abstract P28
   Google Scholar
• Baudry M., Lynch G. Regulation of glutamate receptors by cations. Nature (London) 1979; 282: 748–750
   Google Scholar
• Blume A. J., Lichtshtein D., Boone G. Coupling of opiate receptors to adenylate cyclase: requirement for Na+ and GTP. Proc. Natl. Acad. Sci. USA 1979; 76: 5626–5630
   PubMedGoogle Scholar
• De Vries D. J., Beart P. M. Magnesium ions reveal nanomolar potency of dopamine at [3H] spiperone labelled D-2 receptors in rat corpus striatum. Eur. J. Pharmacol. 1985; 109: 417–419
   Google Scholar
• Grigoriadis D., Seeman P. Complete conversion of brain D2 dopamine receptors from the high-to low- affinity state for dopamine agonists, using sodium ions and guanine nucleotide. J. Neurochem. 1985; 44: 1925–1935
   PubMed Web of Science ®Google Scholar
• Lyengar R., Birnbaumer L. Hormone receptor modulates the regulatory component of adenylyl cyclase by reducing its requirement for Mg2+ and enhancing its extent of activation by guanine nucleotides. Proc. Natl. Acad. Sci. USA 1982; 79: 5179–5183
   Google Scholar
• Lo M. M. S., Snyder S. H. Two distinct solubilized benzodiazepine receptors: differential modulation by ions. J. Neurosci. 1983; 3: 2270–2279
   Google Scholar
• Minuth M., Jakobs K. H. Sodium regulation of agonist and antagonist binding to β-adrenoceoptors in intact and Ns-deficient membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 1986; 333: 124–129
   Google Scholar
• Paterson S. J., Robson L. E., Kosterlitz H. W. Control by cations of opioid binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. USA 1986; 83: 6216–6220
   Google Scholar
• Pert C., Snyder S. H. Properties of opiate-receptor binding in rat brain. Proc. Natl. Acad. Sci. USA 1973; 70: 2243–2247
   PubMed Web of Science ®Google Scholar
• Puttfarcken P., Werling L. L., Brown S. R., Cote T. E., Cox B. M. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at μml and δ-type receptors in 7315c and NG108–15 cells and cell membranes. Mol. Pharmacol. 1986; 30: 81–89
   Google Scholar
• Usdin T. B., Creese I., Snyder S. H. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain. J. Neurochem. 1980; 34: 669–676
   Google Scholar
• Itzhak Y., Khouri M. Regulation of the binding of - and phencyclidine (PCP)-receptor ligands in rat brain membranes by guanine nucleotides and ions. Neurosci. Lett. 1988; 85: 147–152
   Google Scholar
• Haring R., Kloog Y., Harshak-Felixbrodt N., Sokolovsky M. Multiple mode of binding of phencyclidines: High affinity association between phencyclidine receptors in rat brain and a monovalent ion-sensitive polypeptide. Biochem. Biophys. Res.Comm. 1987; 142: 501–510
   Google Scholar
• Haring R., Kloog Y., Kalir A., Sokolovsky M. Binding studies and photoaffinity labeling identify two classes of phencyclidine receptors in rat brain. Biochemistry 1987; 26: 5854–5861
   Google Scholar
• Wolverton W. L., Schuster C. R. Behavioral and pharmacological aspects of opioid dependence: Mixd agonists-antagonists. Pharmacol. Rev. 1983; 35: 33–52
   Google Scholar
• Quirion R., Chicheportiche R., Contreras P. C., Johnson K. M., Lodge D., Tam S. W., Woods J. H., Zukin S. R. Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Neurosci. 1987; 10: 444–446
   Web of Science ®Google Scholar
• Loo P. A., Braunwalder A. F., Lehmann J., Williams M. Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor agonists. Eur. J. Pharmacol. 1986; 123: 467–468
   Google Scholar
• Johnson K. M., Sacaan A. I., Snell L. D. Equilibrium analysis of [3H]TCP binding: Effects of glycine, magnesium and N-methyl-D-aspartate agonist. Eur. J. Pharmacol. 1988; 152: 141–146
   Google Scholar
• Wong E. F., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N., Lversen L. L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA 1986; 83: 7104–7108
   PubMed Web of Science ®Google Scholar
• Church J., Davies S. N., Lodge D. Pentazocine, unlike haloperidol or 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP), is an N-methylaspartate (NMA) antagonist. Neurosci. Lett. 1986, Suppl. 24: S37
   Google Scholar
• Reynolds I. J., Murphy S. N., Miller R. J. [3H]Labeled MK-801 binding to excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc. Natl. Acad. Sci. USA. 1987; 84: 7744–7748
   PubMed Web of Science ®Google Scholar
• Ransom R. W., Stec N. L. Cooperative modulation of [3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J. Neurochem. 1988; 51: 830–836
   PubMed Web of Science ®Google Scholar
• Kemp J. A., Foster A. C., Wong E. H. F. Non-competitive antagonists of excitatory amino acid receptors. Trends Neurosci. 1987; 10: 294–299
   Web of Science ®Google Scholar
• Snell L. D., Johnson K. M. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J. Pharmacol. Exp. Ther. 1986; 238: 938–946
   Google Scholar
• Anis N. A., Berry S. C., Burton N. R., Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-D-aspartate. Br. J. Pharmacol. 1983; 79: 565–575
   PubMed Web of Science ®Google Scholar
• Ascher P. Electrophysiological studies of NMDA receptors. Trends Neurosci. 1987; 10: 284–288
   Web of Science ®Google Scholar
• Huettner J. E., Bean B. P. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: Selective binding to open channels. Proc. Natl. Acad. Sci. USA 1988; 85: 1307–1311
   PubMed Web of Science ®Google Scholar
• Cotman C. W., Monaghan D. T., Ottersen O. P., Storm-Mathisen J. Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci. 1987; 10: 273–280
   Web of Science ®Google Scholar
• Mayer M. L., Westbrook G. L., Guthrie P. B. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature (London) 1984; 309: 262–263
   Google Scholar
• Johnson K. M., Snell L. D., Morter R. S. N-Methyl-D-aspartate enhanced [3H]TCP binding to rat cortical membranes: effects of divalent cations and glycine. Sigma Opioid and Phencyclidine-like Compounds as Molecular Probes in Biology, E. F. Domino, J. M. Kamenka. NPP Press, Ann Arbor 1984; 259
   Google Scholar
• Reynolds I. J., Miller R. J. [3H]MK801 binding to the NMDA receptor/ionophore complex is regulated by divalent cations: Evidence for multiple regulatory sites. Eur. J. Pharmacol. 1988; 151: 103–112
   PubMed Web of Science ®Google Scholar
• Westbrook G. L., Mayer M. L. Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons. Nature (London) 1987; 328: 640–643
   PubMed Web of Science ®Google Scholar
• Mayer M. L., Westbrook G. L. Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse central neurones. J. Physiol. (London) 1987; 394: 501–527
   Google Scholar
• Musacchio J. M., Klein M., Santiago L. J. High affinity dextromethorphan binding sites in guinea pig brain: further characterization and allosteric interactions. J. Pharmacol. Exp. Ther. 1988; 247: 424–431
   PubMed Web of Science ®Google Scholar
• Su T. P., London E. D., Jaffe J. H. Steroid binding at sigma receptors suggest a link between endocrine, nervous, and immune systems. Science 1988; 240: 219–221
   PubMed Web of Science ®Google Scholar
• McLean S., Weber E. Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain. Neuroscience 1988; 25: 259–269
   PubMed Web of Science ®Google Scholar
• McCann D. J., Rabin R. A., Rens-Domiano S., Winte J. C. Phencyclidine/SKF-10,047 binding sites: evaluation of function. Pharmacol. Biochem. Behav. 1989; 32: 87–94
   Google Scholar
• Walker J. M., Matsumoto R. R., Bowen W. D., Gans D. L., Jones K. D., Walker F. O. Evidence for a role of haloperidol-sensitive sigma-‘opiate’ receptors in the motor effects of antipsychotic drugs. Neurology 1988; 38: 961–965
   Google Scholar
• Sonders M. S., Keana J. F. W., Weber E. Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. Trends Neurosci. 1988; 11: 37–40
   Google Scholar
• Manallack D. T., Beart P. M., Gundlach A. L. Psychotomimetic sigma-opiates and PCP. Trends Pharmacol. Sci. 1986; 7: 445–451
   Google Scholar
• Schwarz S., Zhou G. Z., Katki A. G., Rodbard D. L-Homocysteate stimulates [3H]MK-801 binding to the phencyclidine recognition site and is thus an agonist for the N-methyl-D-aspartate-operated cation channel. Neuroscience 1989, in press
   Google Scholar
• Bowen W. D., Kirschner B. N., Newman A. H., Rice K. C. Sigma receptors negatively modulate agonist-stimulated phosphoinositide metabolism in brain. Eur. J. Pharmacol. 1988; 149: 399–400
   Google Scholar